Comparative Analysis of Medicines Safety Advisories Released by Australia, Canada, the United States, and the United Kingdom

被引:19
|
作者
Perry, Lucy T. [1 ,2 ]
Bhasale, Alice [1 ,2 ]
Fabbri, Alice [1 ,2 ]
Lexchin, Joel [3 ]
Puil, Lorri [4 ]
Joarder, Maisah [1 ,2 ]
Mintzes, Barbara [1 ,2 ]
机构
[1] Univ Sydney, Fac Med & Hlth, Charles Perkins Ctr, Sydney, NSW, Australia
[2] Univ Sydney, Fac Med & Hlth, Sch Pharm, Sydney, NSW, Australia
[3] York Univ, Sch Hlth Policy & Management, Fac Hlth, Toronto, ON, Canada
[4] Univ British Columbia, Fac Med, Dept Anaesthesiol Pharmacol & Therapeut, Vancouver, BC, Canada
基金
加拿大健康研究院; 英国医学研究理事会;
关键词
RISK;
D O I
10.1001/jamainternmed.2019.0294
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This study examines how often medicines regulators in Australia, Canada, the United Kingdom, and the United States were concordant in their decisions to issue safety advisories on approved prescription medicines.
引用
收藏
页码:982 / 984
页数:3
相关论文
共 50 条